16.08.2008 at 08:00
- Category:
Cancer and Oncology
Current study results from the report, 'Stress, immunity, and cervical cancer: biobehavioral outcomes of a randomized clinical trial,' have been published. According to recent research from the United States, "Cancer diagnosis and treatment imparts chronic stressors affecting quality of life (QOL) and basic physiology. However, the capacity to increase survival by improving QOL is controversial."
"Patients with cervical cancer, in particular, have severely compromised QOL, providing a population well-suited for the evaluation of novel psychosocial interventions and the exploration of mechanisms by which modulation of the psychoneuroimmune axis might result in improved clinical outcomes. A randomized clinical trial was conducted in cervical cancer survivors that were enrolled at >or and Cervical Cancer Quality of Care).
The researchers concluded: "These data support the integration of the chronic stress response into biobehavioral models of cancer survivorship and suggests a novel mechanistic hypotheses by which interventions leading to enhanced QOL could result in improved clinical outcome including survival."
Nelson and colleagues published their study in Clinical Cancer Research (Stress, immunity, and cervical cancer: biobehavioral outcomes of a randomized clinical trial [corrected]. Clinical Cancer Research, 2008;14(7):2111-8).
For additional information, contact E.L. Nelson, University of California, Dept. of Medicine, Irvine, California 92697 USA..
Publisher contact information for the journal Clinical Cancer Research is: American Association Cancer Research, 615 Chestnut St., 17TH Floor, Philadelphia, PA 19106-4404, USA.
Copyright 2008, Oncology Business Week via NewsRx.com
